Drug profile · INN
amphetamine
DYANAVEL XR 20
amphetamine (DYANAVEL XR 20) is a norepinephrine transporter releasing agent. Route of administration: oral. Current US regulatory status: approved.
Drug details — amphetamine
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 1
- Programs
- 55
- Data quality
- 0.84
Quick answer
amphetamine (DYANAVEL XR 20) is a norepinephrine transporter releasing agent. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Norepinephrine transporter releasing agent
Primary target: Sodium-dependent dopamine transporter
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is amphetamine?
amphetamine (DYANAVEL XR 20) is a norepinephrine transporter releasing agent. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for amphetamine?
DYANAVEL XR 20 is a marketed brand name for amphetamine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of amphetamine?
amphetamine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.